Related Experiment Video
Updated: Jul 19, 2026

Assay Development for High-Throughput Drug Screening Against Mycobacteria
Published on: October 25, 2024
Selection of retapamulin, a novel pleuromutilin for topical use
Stephen Rittenhouse1, Sanjoy Biswas, John Broskey
1Department of Microbiology Research, MMPD CEDD, GlaxoSmithKline Pharmaceuticals, 1250 S. Collegeville Rd, Collegeville, PA 19426-0989, USA. Stephen_Rittenhouse@GSK.com
Abstract:
The in vitro activity of retapamulin was determined and compared to that of topical and community antibiotics. The MIC(90)s of retapamulin against Staphylococcus aureus and Streptococcus pyogenes were 0.12 microg/ml and 0.016 microg/ml, respectively. Retapamulin has a low propensity to select resistance and produces an in vitro postantibiotic effect.
Related Concept Videos
Anthelminthic Agents
Antiprotozoal Agents
Antifungal Agents
Clinical Significance of Antibiotic Resistance
Hand hygiene
Hand washing...
